Ratings by Lucid Capital Markets (Alex Nowak)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/12/2026 | Prenetics | PRE | New Coverage | Buy (N/A) |
21.84 (18.52) |
-15.2% | Details | |
| 9/28/2026 | LENSAR Inc. | LNSR | New Coverage | Buy (N/A) |
6.92 (5.80) |
-16.18% | Details | |
| 9/2/2026 | Xtant Medical | XTNT | New Coverage | Buy (N/A) |
0.37 (0.29) |
-21.62% | Details | |
| 8/24/2026 | Insight Molecular Diagnostics Inc. | IMDX | New Coverage | Buy (N/A) |
4.34 (3.01) |
-30.65% | Details | |
| 7/27/2026 | Envoy Medical | COCH | New Coverage | Buy (N/A) |
0.66 (0.67) |
1.52% | Details | |
| 6/3/2026 | SS Innovations Int'l | SSII | New Coverage | Buy (N/A) |
4.01 (2.53) |
-36.91% | Details | |
| 6/3/2026 | Microbot Medical | MBOT | New Coverage | Buy (N/A) |
2.01 (0.95) |
-52.74% | Details | |
| 6/3/2026 | Adagio Medical Holdings | ADGM | New Coverage | Buy (N/A) |
0.78 (0.10) |
-87.18% | Details |
